Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.22M Sell
1,786,765
-292,378
-14% -$475K ﹤0.01% 3399
2026
Q1
$3.68M Buy
2,079,143
+1,881,200
+950% +$10.6M ﹤0.01% 3278
2025
Q4
$1.29M Sell
197,943
-302,323
-60% -$1.57M ﹤0.01% 4304
2025
Q3
$2.31M Sell
500,266
-1,008,932
-67% -$1.63M ﹤0.01% 3917
2025
Q2
$1.68M Buy
1,509,198
+476,180
+46% +$673K ﹤0.01% 4028
2025
Q1
$1.45M Buy
1,033,018
+876,382
+560% +$1.8M ﹤0.01% 4077
2024
Q4
$594K Buy
156,636
+142,814
+1,033% +$890K ﹤0.01% 4610
2024
Q3
$118K Buy
+13,822
New +$164K ﹤0.01% 5549
2024
Q1
Sell
-19,807
Closed -$135K 6530
2023
Q4
$135K Buy
19,807
+3,496
+21% +$19.2K ﹤0.01% 5269
2023
Q3
$82.9K Sell
16,311
-1,419
-8% -$9.05K ﹤0.01% 5381
2023
Q2
$159K Buy
17,730
+7,280
+70% +$95.2K ﹤0.01% 5210
2023
Q1
$128K Buy
+10,450
New +$164K ﹤0.01% 5335
2022
Q4
Sell
-360,941
Closed -$3.28M 6925
2022
Q3
$3.28M Buy
360,941
+151,175
+72% +$1.49M ﹤0.01% 3298
2022
Q2
$2.08M Buy
+209,766
New +$2.34M ﹤0.01% 3669

Other funds holding PEPG

Israel Englander's PEPG Position: Q2 2026 in Review

Israel Englander reduced its PepGen (PEPG) stake by 14% in Q2 2026, selling an estimated $475K and leaving 1,786,765 shares worth $3.22M. The position accounts for ﹤0.01% of the portfolio, ranked #3399.

Israel Englander first reported a position in PEPG in Q2 2022 and has held it in 14 quarters since. The position peaked at $3.68M in Q1 2026. 72 funds tracked by Wall St. Rank hold PEPG as of Q2 2026.

  • Israel Englander held 1,786,765 shares of PepGen worth $3.22M as of Q2 2026.
  • Israel Englander sold 292,378 PepGen shares in Q2 2026, an estimated $475K.
  • PepGen made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3399 holding.
  • Israel Englander first reported a position in PepGen in Q2 2022 and has held it in 14 quarters since.
  • Israel Englander's PepGen position peaked at $3.68M in Q1 2026.
  • 72 funds tracked by Wall St. Rank held PepGen as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.